Workflow

John Orosco, Red Rover Health's CEO, says the company's API-based platform that integrates digital tools directly into EHRs can help streamline operations and reduce clinician burnout.

Philipp von Gilsa, CEO of kontakt.io, says the company's real-time location services provide location information for equipment to increase utilization rates and enable clinicians to quickly call for help using wearable duress buttons.

Penn Medicine's Anna Schoenbaum says the HIMSS Nursing Innovation Advisory Workgroup, which she co-chairs, has developed AI toolkits and customizable teaching slides to help leaders understand AI's complexity, costs and impact.

Edward Marx, CEO of Marx Advisory, recommends that healthcare leaders looking to drive innovation in their organizations become innovative themselves by bringing their C-suite to meet with and learn from partners.

Anne Osdoit, CEO of Moon Surgical, says the company’s robotic surgery offering serves as a surgical assistant in laparoscopic soft tissue procedures, using robotic arms to hold instruments and AI to give insights into workflow efficiency.

From documenting bedside prayers to helping a hard-of-hearing nurse connect with patients, AI tools are revealing the importance of nurses' and patients' emotional and spiritual bonds to healing, says Mercy's Tracy Breece.

According to Tony DiGiorgio, chief architect at Symplr, the company has carefully embedded AI into its operational platform to cut administrative redundancy and enable nurses to minimize the number of systems they use each day.

Sara Meinke and Asad Tariq of Baptist Health discuss how a predictive analytics tool has helped reduce patient wait times and enabled nurses to have uninterrupted lunch breaks, increasing patient and staff satisfaction.

Through working with global leaders, educating its members and developing digital transformation tools for health systems, Hal Wolf, HIMSS president and CEO, says HIMSS encourages the ethical and practical integration of AI in healthcare.

Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.